Neuroimaging in Alzheimer disease: an evidence-based review.
about
The limbic systemThe effect of body mass index on global brain volume in middle-aged adults: a cross sectional studyMild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's diseaseThe diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAdvances in the treatment of anxiety: targeting glutamate.Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.Anteroposterior hippocampal metabolic heterogeneity: three-dimensional multivoxel proton 1H MR spectroscopic imaging--initial findings.N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.MR spectroscopy, functional MRI, and diffusion-tensor imaging in the aging brain: a conceptual review.Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage.Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria.Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease.The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques.Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease.Structural and functional neuroimaging methods in the diagnosis of dementias: a retrospective chart and brain imaging review.A biomarker for severity of Alzheimer's disease: 1H-NMR resonances in cerebrospinal fluid correlate with performance in mini-mental-state-exam.The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.The relationship between cortical blood flow and sub-cortical white-matter health across the adult age span.Sensitivity and specificity of diagnostic accuracy in Alzheimer's disease: a synthesis of existing evidence.Reduced hippocampal volume correlates with executive dysfunctioning in major depression.Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.Hippocampal morphometry in population-based incident Alzheimer's disease and vascular dementia: the HAAS.Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imagingPrediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance.Alzheimer's disease: a clinical practice-oriented review.Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCITranslational research in central nervous system drug discovery.The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease.Feed-forward hierarchical model of the ventral visual stream applied to functional brain image classificationRegional cerebral blood flow reductions, heart failure and Alzheimer's disease.MRI parameters of Alzheimer's disease in an Arab population of Wadi Ara, Israel.The Framingham Brain Donation Program: neuropathology along the cognitive continuum.Effects of spatial transformation on regional brain volume estimates.Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls.Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease.Changes in cerebral morphometry and amplitude of low-frequency fluctuations of BOLD signals during healthy aging: correlation with inhibitory controlAutomatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer diseaseDepressive symptoms and brain volumes in older adults: a longitudinal magnetic resonance imaging study.Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
P2860
Q24595770-0EFECA22-9814-4068-8BC6-FE59334235F1Q25255299-9042489F-4AEB-4DF2-9D13-9727BB037630Q27027319-3CA712F5-FE49-4153-A486-34299BD0801DQ29614406-F5752717-714C-40EB-BB83-2FE6D04495E7Q30457479-7527CF53-D6BF-4477-A9CF-AC1458A5646AQ31159878-EC967A58-F53B-4FE4-BE20-DFB437CB941AQ31171177-1E122608-5CBA-4FDB-8018-AE2163BE51C2Q33271816-85FD01E0-68D2-4DB5-A3FC-5ED53CC42100Q33277156-85176FC3-CF36-4B7A-BBFB-13FE8E0E69DFQ33345777-AAE0EEBF-83F8-483B-BB2A-776F76681062Q33624213-AB8F41FB-8146-44F4-90FC-670D2075772EQ33727158-24FA5288-A655-4157-B43F-0D15EA2766A5Q33875000-3680C651-2357-43CB-9710-7E3D05304C14Q33947426-00430190-6728-4629-9737-AFCDED7E5941Q34006368-FBBE2B70-0844-4A37-BA33-25E780B83AFCQ34144542-E603FB03-50F1-4430-9121-D1C9ABADC697Q34296479-31ED4E98-699E-4026-8D0D-3387F2756451Q34599407-E97480E7-3E18-4358-A0AE-73DEC9D23AAAQ34728483-528B40B6-53FF-4702-8B77-52B8815A6C55Q35012657-0B6413EF-52FC-4B9A-BAF0-187E80C7C011Q35034130-4195A50A-CB94-40D9-BBE5-06A0D51743DAQ35340038-FE161AF5-5473-401E-9189-19D20E5E23DFQ35677174-2363F043-9A17-4C3A-976E-D54F0CADAE23Q35894767-D9E4E6D1-F7B1-437D-8127-434206F5EEFEQ35899503-E5A5BA93-DEEA-4883-9068-B68D28E115EDQ36022784-9067E47B-815C-43A9-93ED-34D879F42DC0Q36368924-2923882B-7BC4-403A-A38B-CBB49F8CDD3CQ36401418-F8270E22-A802-42C8-89B7-69CF7E321EC0Q36496436-803B94C4-36BA-44AA-8887-37EA72EC97E8Q36557817-7CA236BA-E956-4AD3-864A-94E0D3573C6DQ36582762-B6BBF139-3E82-4F84-A06D-E3101929DDE9Q36718047-4D12BFBB-E9A6-4A0F-A8C0-D888DEAD88F9Q36755746-7A465E10-938F-49E6-9086-04955ECA57CBQ36969417-D9A1719C-7FF2-45C6-ABFD-E38E1A95FBE1Q37057995-8BE1911E-A10F-44D7-8688-E67AA1ABB602Q37130132-774D6F3F-B795-4000-9A4D-43E5FE96BEC5Q37141912-25BBC200-7DA6-4EDA-94BB-99632B0C0B48Q37298212-B964CE55-4152-4605-A475-91091D78CB77Q37320815-CA65EB41-0EA7-404E-BD0A-316BC36C9A11Q37323665-8D485A56-2CB3-4108-93A1-A0CDB2EF8D92
P2860
Neuroimaging in Alzheimer disease: an evidence-based review.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Neuroimaging in Alzheimer disease: an evidence-based review.
@ast
Neuroimaging in Alzheimer disease: an evidence-based review.
@en
type
label
Neuroimaging in Alzheimer disease: an evidence-based review.
@ast
Neuroimaging in Alzheimer disease: an evidence-based review.
@en
prefLabel
Neuroimaging in Alzheimer disease: an evidence-based review.
@ast
Neuroimaging in Alzheimer disease: an evidence-based review.
@en
P1476
Neuroimaging in Alzheimer disease: an evidence-based review.
@en
P304
P356
10.1016/S1052-5149(03)00025-X
P407
P577
2003-05-01T00:00:00Z